C12N 2710/16145
Special targeting system for viral vectors
C12N2710/16145 (Special targeting system for viral vectors) appears on 2 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 7
- Assignees
- 5
- Inventors
- 19
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 3 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Herpesviral combination therapy for targeting cancer cells and cancer associated stromal cells11 Jun 2026US 2026/0158087 A1Mayo Foundation for Medical Education and Research
- Expression vectors, bacterial sequence-free vectors, and methods of making and using the same11 Jul 2024US 2024/0229071 A1Mediphage Bioceuticals, Inc.
- Targeted rna editing by leveraging endogenous adar using engineered rnas16 Nov 2023US 2023/0365962 A1Peking University
- Targeted rna editing by leveraging endogenous adar using engineered rnas4 Aug 2022US 2022/0243194 A1Peking University
- Targeted rna editing by leveraging endogenous adar using engineered rnas5 May 2022US 2022/0135963 A1Peking University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.